Stockreport

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update [Yahoo! Finance]

Kezar Life Sciences, Inc.  (KZR) 
Last kezar life sciences, inc. earnings: 8/7 04:05 pm Check Earnings Report
PDF PORTOLA Phase 2a clinical trial of zetomipzomib in patients with autoimmune hepatitis actively enrolling; reiterating guidance of topline data in mid-2025 KZR-261 dos [Read more]